By Randy Dotinga
MONDAY, June 30, 2014 (HealthDay News) — A combination drug used to treat and prevent HIV — Truvada — may have an additional benefit: lowering the risk of a genital herpes infection, a new study suggests.
Researchers found that African heterosexuals who were at risk of getting HIV from their partners were about 30 percent less likely to get infected with genital herpes if they took the drug tenofovir alone or with emtricitabine. Truvada is made from the combination of these two drugs.
The study isn’t likely to lead physicians to use tenofovir — alone or in combination with emtricitabine — solely to prevent herpes, one infectious-disease specialist said.
“No one is going to use tenofovir specifically to reduce herpes. There are some side effects and the drug is not cheap. It will only be used as prevention for HIV — not herpes — for…
View original post 574 more words